ADRENOCORTICAL CARCINOMA (ACC)
Clinical trials for ADRENOCORTICAL CARCINOMA (ACC) explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA (ACC) trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA (ACC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach before surgery for rare adrenal cancer
Disease control Recruiting nowThis early-phase trial tests giving radiation therapy before surgery to people whose adrenal cancer has come back. The goal is to find a safe radiation dose and see if it helps shrink tumors before removal. About 32 adults with resectable recurrent ACC will receive daily radiatio…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for liver metastases: immune booster combined with targeted chemo
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard chemotherapy delivered directly to the liver can help people with colorectal, bile duct, or adrenal cancer that has spread to the liver. About 70 adults will receive the drug combination along with a s…
Matched conditions: ADRENOCORTICAL CARCINOMA (ACC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC